What is NBIX's EasyStocksAI score?

Neurocrine Biosciences Inc (NBIX) scores 32 out of 100 on EasyStocksAI's Graham-inspired scoring system. Breakdown: Total Shareholder Yield: 0/25, Return Consistency: 0/25, Return Growth: 0/25, Payment Regularity: 0/25, Revenue Growth: 6/25, Earnings Growth: 0/25, Margin Trend: 2/25, Capital Efficiency: 0/25, P/E vs Sector: 0/25, Graham Ratio Trend: 0/25, Price Stability: 0/25, Earnings Yield: 1/25, 10Y SPY Outperformance: 0/25, 10Y Sector Outperformance: 8/25, Crisis Resilience: 15/25.

Does NBIX pay dividends?

Neurocrine Biosciences Inc does not currently pay a regular dividend.

Neurocrine Biosciences Inc's Graham Number is 58.37. The current price of 127.78 is above the Graham Number.

How does NBIX compare to the Health Care sector?

Neurocrine Biosciences Inc has a P/E ratio of 27.85 in the Health Care sector.

insights

EasyStocksAI

NBI

NBIX

Neurocrine Biosciences Inc

$127.78 arrow_downward $1.76 (1.36%)

AI Score

N/A

Loading chart…

Loading chart...

analytics Financial Highlights

P/E Ratio 27.85

Dividend Yield 0.00%

Graham Number 58.37

Market Cap $13.1B

Div. Increase Years 0

Continuous Years 0

Crises Survived 5

speed Performance Benchmarks

vs S&P 500 (10Y) -90.07%

vs Sector (10Y) +111.46%

speed Market Sentiment

Fear

OVERALL MARKET CONFIDENCE

show_chart Trend Analysis

Primary Trend

● Neutral

Secondary Trend Bearish

Warning Price dropped below 20-day MA

MA 20

129.70

MA 50

133.59

MA 200

136.81

analytics Sector Comparison (Health Care)

P/E Ratio —

Graham Ratio —

Track NBIX and 1,000+ stocks for free

Get scores, alerts, and portfolio tracking — no credit card required.

Start Free →